Health Technology Assessment (HTA) guidelines outline the principles and methods used in assessing health technologies. The purpose of such guidelines is to promote the production of assessments that are timely, reliable, consistent and relevant to the needs of decision makers and key stakeholders in Ireland. The first set of guidelines i.e. Irish Healthcare Technology Assessment Guidelines were introduced in 2000.
Since then, guideline updates have taken into account developments in pharmacoeconomics and the requirements of key stakeholders. The new guidelines comprise of several sections including guidance on economic evaluation, budget impact analysis, social, ethical and organisational aspects of HTA and recommended reporting formats. The guidelines were developed in consultation with the Scientific Advisory Group of the Authority.
National Guidelines:
Guidelines for Economic Evaluation of Health Technologies in Ireland
Guidelines for Evaluating the Clinical Effectiveness of Health Technologies in Ireland
Guidelines for the Budget Impact Analysis of Health Technologies in Ireland
NCPE Guidelines:
Guidelines for Inclusion of Drug Costs in Pharmacoeconomic Evaluations v3.2
